Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hamba Yigezu"'
Autor:
Firafan Shuma Teka, Ayana Tadesse Korsa, Habte Gebeyehu Bayisa, Hamba Yigezu Fida, Birbirsa Sefera Senbeta
Publikováno v:
Thrombosis Update, Vol 15, Iss , Pp 100170- (2024)
Abstracts: Background: Management with warfarin therapy becomes challenging globally due to the increased risk of adverse clinical outcomes from its use. In Africa, warfarin-related bleeding events and thromboembolic complications range from 0.006 %
Externí odkaz:
https://doaj.org/article/723463850a484d188512e6225b41ad7d
Autor:
Hamba Yigezu, Juhar Temam, Mitiku Bajiro, Leta Tesfaye Jule, N. Nagaprasad, Arpita Roy, Abel Saka, Krishnaraj Ramaswamy
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2022 (2022)
Background. Hepatitis B is a severe, widespread infectious disease of the liver that affects millions of people around the world. It is one of the life-threatening liver infections caused by the hepatitis B virus (HBV). HBV is the cause of up to 80%
Externí odkaz:
https://doaj.org/article/8c98b50af8ae403d8a990d976cac1228
Autor:
Shuma Teka, Firafan, Korsa, Ayana Tadesse, Bayisa, Habte Gebeyehu, Fida, Hamba Yigezu, Senbeta, Birbirsa Sefera
Publikováno v:
In Thrombosis Update June 2024 15
Autor:
Hamba Yigezu, Juhar Temam, Mitiku Bajiro, Leta Tesfaye Jule, N. Nagaprasad, Arpita Roy, Abel Saka, Krishnaraj Ramaswamy
Publikováno v:
Canadian journal of gastroenterologyhepatology. 2022
Background. Hepatitis B is a severe, widespread infectious disease of the liver that affects millions of people around the world. It is one of the life-threatening liver infections caused by the hepatitis B virus (HBV). HBV is the cause of up to 80%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c91909c2aed714ed123c39f1a2d5971e
https://pubmed.ncbi.nlm.nih.gov/35655943
https://pubmed.ncbi.nlm.nih.gov/35655943